Logo
Whalesbook
HomeNewsCorporate NewsPremiumStocks
HomeNewsCorporate NewsPremiumStocks

Hemo Organic Ltd

₹ 16.8-1.98%
16 Jan – close price
🔗hemoorganicltd.comâ€ĸBSE: 524590â€ĸNSE:
Market Cap₹ 5.83 Cr.
Current Price₹ 16.8
High / Low₹ 22.5
Stock P/E48.6
Book Value₹ -0.75
Dividend Yield0.00 %
ROCE2.65 %
ROEnull %
Face Value₹ 10.0
Sales₹ 2.41 Cr.
OPM-5.39 %
Mar Cap₹ 5.83 Cr.

ABOUT

Incorporated in 1992, Hemo Organic Ltd is in the business of trading & distribution of Rice and Textiles.

KEY POINTS

Business Overview:[1]HOL is engaged in agro trading across domestic and international markets. Its activities include buying, selling, reselling, importing, exporting, transporting, storing, developing, promoting, marketing, and supplying goods. The company operates at both retail and wholesale levels.

Also present in buckets:
Aggressive Growth TriggersExcellent ResultsAsset Base ExpansionAsset Base ExpansionPreferential IssuancePreferential IssuanceOrder Book PositionLarge Order ReceiptsJv Partnerships AcquisitionsCredit Rating UpdatesRed Flags And Poor PerformanceRed Flags And Poor Performance

Peer Comparision

S.No.NameCurrent Price (Rs.)Price to EarningMarket Capitalization (Rs.Cr.)Dividend yield (%)Net Profit latest quarter (Rs.Cr.)YOY Quarterly profit growth (%)Sales latest quarter (Rs.Cr.)YOY Quarterly sales growth (%)Return on capital employed (%)Sales (Rs.Cr.)OPM (%)Profit after tax (Rs.Cr.)Profit after tax latest quarter (Rs.Cr.)Price to book valueReturn on assets (%)Debt to equity
1.Redington263.5015.0920622.372.58350.2032.4229075.6116.7918.90108183.362.021366.24387.832.295.110.29
2.MMTC68.87146.5810304.590.00170.81-2.381.10-29.497.702.94-3501.7070.3020.505.372.720.02
3.BN Agrochem352.0551.123442.100.0017.92414.94216.49–27.44719.21-1.0667.3417.927.7516.400.20
4.MSTC477.0515.183354.278.4947.5010.7785.0118.2029.26332.4358.23220.9747.504.049.980.17
5.Vintage Coffee155.1437.272242.230.0617.83137.42135.6189.5115.42430.5117.6160.1617.834.2611.480.17
6.TCC Concept449.8545.232138.050.0010.4312.7326.9360.0111.83103.6374.7747.2710.452.188.350.05
7.RRP Defense890.55488.691221.730.001.5915800.005.307471.4382.7214.1220.612.501.5980.4814.460.00
8.Hemo Organic16.8148.605.830.00-0.0362.500.00–2.652.41-5.390.12-0.03–5.30–
–Median: 53 Co.118.737.02234.910.01.7716.5742.7611.157.7144.412.817.351.692.93.050.17

Quarterly Results

Standalone figures in ₹ crores

Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales
0.000.000.000.000.000.000.000.020.000.000.002.410.000.00
Expenses
0.000.000.000.050.04-0.010.000.230.000.080.132.260.110.04
Operating Profit
0.000.000.00-0.05-0.040.010.00-0.210.00-0.08-0.130.15-0.11-0.04
Other Income
0.000.000.000.000.000.000.000.000.000.000.000.090.000.00
Profit before tax
0.000.000.00-0.05-0.040.010.00-0.230.00-0.08-0.130.24-0.11-0.04
Tax %
–––0.00%0.00%0.00%–0.00%–0.00%0.00%-58.33%-27.27%-25.00%
Net Profit
0.000.000.00-0.05-0.040.010.00-0.230.00-0.08-0.130.37-0.09-0.03
EPS in Rs
0.000.000.00-0.14-0.120.030.00-0.660.00-0.23-0.381.07-0.26-0.09

Profit & Loss

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
0.710.160.110.600.090.050.270.010.010.000.022.412.41
Expenses
0.790.220.160.680.240.170.290.060.070.050.262.452.54
Operating Profit
-0.08-0.06-0.05-0.08-0.15-0.12-0.02-0.05-0.06-0.05-0.24-0.04-0.13
Other Income
0.230.02-0.710.000.000.000.000.000.000.000.000.070.09
Interest
0.020.000.000.000.000.000.000.000.000.000.020.000.00
Depreciation
0.090.070.060.000.000.000.000.000.000.000.000.000.00
Profit before tax
0.04-0.11-0.82-0.08-0.15-0.12-0.02-0.05-0.06-0.05-0.260.03-0.04
Net Profit
0.04-0.11-0.82-0.08-0.15-0.12-0.02-0.05-0.06-0.05-0.260.160.12
EPS in Rs
0.12-0.32-2.37-0.23-0.43-0.35-0.06-0.14-0.17-0.14-0.750.460.34
Dividend Payout %
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%–

Compounded Sales Growth

10 Years:31%
5 Years:55%
3 Years:522%
TTM:11950%

Compounded Profit Growth

10 Years:13%
5 Years:58%
3 Years:67%
TTM:139%

Stock Price CAGR

10 Years:-2%
5 Years:0%
3 Years:22%
1 Year:68%

Return on Equity

10 Years:%
5 Years:%
3 Years:%
Last Year:%

Balance Sheet

Standalone figures in ₹ crores

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
3.403.403.403.473.473.473.473.473.473.473.473.473.47
Reserves
-1.92-2.16-2.98-3.06-3.21-3.33-3.35-3.40-3.46-3.52-3.78-3.62-3.73
Borrowings
0.050.050.000.000.080.080.000.040.040.041.241.481.64
Other Liabilities
0.140.080.110.720.660.730.130.120.190.350.133.653.96
Total Liabilities
1.671.370.531.131.000.950.250.230.240.341.064.985.34
Fixed Assets
1.120.920.000.000.000.000.000.000.000.000.000.000.00
Gross Block
2.332.330.000.000.000.000.000.000.000.000.000.00–
Accumulated Depreciation
1.211.410.000.000.000.000.000.000.000.000.000.00–
CWIP
0.000.000.000.000.000.000.000.000.000.000.000.000.00
Investments
0.000.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets
0.550.450.531.131.000.950.250.230.240.341.064.985.34
Total Assets
1.671.370.531.131.000.950.250.230.240.341.064.985.34

Cash Flows

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity
0.060.06-0.78-0.15-0.12-0.040.01-0.010.000.11-1.19-0.36
Cash from Investing Activity
0.020.000.700.020.060.040.000.000.000.000.000.00
Cash from Financing Activity
-0.170.000.080.150.000.000.000.000.000.001.200.24
Net Cash Flow
-0.090.070.000.01-0.06-0.010.01-0.010.000.110.01-0.12

Ratios

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
159.37342.190.00438.002,920.005,402.0094.632,555.002,190.00–1,460.00381.66
Inventory Days
0.000.000.0020.6691.250.000.000.00730.00––143.18
Days Payable
–––392.553,011.25–––4,015.00––366.01
Cash Conversion Cycle
159.37342.190.0066.110.005,402.0094.632,555.00-1,095.00–1,460.00158.83
Working Capital Days
71.97114.06232.27146.00689.44438.00-67.59-1,825.00-4,015.00–11,862.50156.00
ROCE %
-10.56%-7.80%-12.87%-19.28%-40.00%-42.86%-11.76%-43.48%-75.00%-250.00%-52.17%2.65%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters
16.85%16.85%16.85%16.85%16.85%16.85%16.85%16.85%16.85%16.85%16.85%16.85%
FIIs
––––––––––––
DIIs
––––––––––––
Public
83.15%83.15%83.15%83.15%83.15%83.15%83.16%83.15%83.15%83.15%83.15%83.15%

* The classifications might have changed from Sep'2022 onwards.ℹī¸

BSE Announcements AI Summary

Direct from BSE filings, auto-summarised

Hemo Organic Files SEBI Compliance Certificate for March 2026 Quarter

9th April 2026, 10:18 pm

Hemo Organic: Independent Director Resigns Effective March 31, 2026

31st March 2026, 10:20 pm

Hemo Organic Limited: Director Resignation Accepted; Committees Re-constituted

31st March 2026, 10:10 pm

HEMO ORGANIC LIMITED Closes Trading Window from April 1st Ahead of Financial Results

25th March 2026, 10:34 pm

Hemo Organic Limited Shifts Registered Office

26th February 2026, 8:35 pm

Published by Other Websites

External media mentions & references

Indian Market Cap Soars Past Rs 473 Lakh Crore! Sensex, Nifty Edge Higher - Don't Miss This Crucial Update!

13th November 2025, 4:49 pm

Indian Markets Show Mixed Performance: BSE Sensex Edges Lower, Nifty-50 Rises

2nd September 2025, 7:34 pm

HEMO ORGANIC LIMITED Closes Trading Window from April 1 for FY26 Results
Hemo Organic Ltd Files Q4 FY26 RTA Compliance Certificate
Hemo Organic Allots ₹4.25 Cr Warrants, Nearly Doubles Paid-up Capital

News Articles

Editorial & research coverage

Indian Market Cap Soars Past Rs 473 Lakh Crore! Sensex, Nifty Edge Higher - Don't Miss This Crucial Update!
Indian Market Cap Soars Past Rs 473 Lakh Crore! Sensex, Nifty Edge Higher - Don't Miss This Crucial Update!

13th November 2025, 4:49 pm

Documents

Announcements

Submission Of Voting Result Of Extra Ordinary General Meeting Of M/S. Hemo Organics Limited
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

9 Jan - Scrutinizer report: EGM on Jan 7, 2026; resolutions 1&2 passed unanimously (100% votes in favour).

Shareholder Meeting / Postal Ballot-Outcome of EGM

7 Jan - EGM on 7-Jan-2026 considered authorised capital increase and preferential convertible warrants to non-promoters; voting results pending.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

6 Jan - Submission of Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter and nine months ended December 31, 2025.

Closure of Trading Window

Annual Reports

Financial Year 2025

(from bse)

Financial Year 2024

(from bse)

Financial Year 2023

(from bse)

Financial Year 2022

(from bse)

Financial Year 2021

(from bse)

Financial Year 2020

(from bse)

Financial Year 2019

(from bse)

Financial Year 2018

(from bse)

Financial Year 2017

(from bse)

Financial Year 2016

(from bse)

Financial Year 2015

(from bse)

Financial Year 2014

(from bse)

Financial Year 2013

(from bse)

Financial Year 2012

(from bse)

Financial Year 2011

(from bse)

Credit Ratings

No credit ratings.

Concalls

No concalls.

Stock Analysis

Description

  1. Hemo Organic Limited is engaged in the trading and distribution of rice and textiles, operating in both domestic and international markets.

Key Growth Triggers

  1. The primary trigger discussed is the approved preferential issue of warrants to raise approximately ₹12.47 crore, intended to strengthen working capital. This aims to support operations amidst previous financial turnaround efforts, though persistent auditor concerns and high debt levels persist.

Order Book

  1. Currently no data available for Order Book.

Key Red Flags

  1. Persistent qualified opinion from auditors regarding trade receivables and payables due to insufficient documentation.
  2. Significant increase in borrowings, raising concerns about leverage.
  3. Continued presence of negative reserves, impacting the company's financial stability.
  4. Low promoter holding, historically a point of concern.

Key Dates To Watch

  1. January 7, 2026: Extra-Ordinary General Meeting (EGM) held, approving preferential issue and capital increase.

Corporate Announcements

9th Apr 26
Impact Rating: 6
Hemo Organic Limited submitted its SEBI compliance certificate for the quarter ending March 31, 2026. The filing confirms proper processing of dematerialized securities and cancellation of physical share certificates.
31st Mar 26
Impact Rating: 5
Hemo Organic Limited announced the resignation of Independent Director Mr. Deepak Ashokkumar Rochani, effective March 31, 2026. His departure is due to professional commitments and he will leave all board committees.
31st Mar 26
Impact Rating: 4
Hemo Organic Limited announced the resignation of Independent Director Mr. Deepak Ashokkumar Rochani, effective March 31, 2026, citing pre-occupation. The Board also approved the re-constitution of the Audit, Nomination and Remuneration, and Stakeholders Grievance committees with new member compositions from April 1, 2026.
25th Mar 26
Impact Rating: 7
HEMO ORGANIC LIMITED has announced its trading window for dealing in equity shares will be closed starting April 1, 2026. The window will reopen 48 hours after the declaration of the audited financial results for the quarter and year ended March 31, 2026.
26th Feb 26
Impact Rating: 2
Hemo Organic Limited informed the stock exchange that its Board of Directors approved shifting the company's registered office to a new location within Ahmedabad, Gujarat. The effective date for this change is February 26, 2026.